LONG TERM OUTCOMES AND RISK FACTORS FOR CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY IN CHILDHOOD CANCER SURVIVORS

被引:0
|
作者
Kandula, Tejaswi [1 ]
Farrar, Michelle [1 ]
Kieman, Matthew [2 ]
Mizrahi, David [3 ]
Carey, Kate [1 ]
Krishnan, Arun [4 ]
Cohn, Richard [5 ]
Park, Susanna [2 ]
机构
[1] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[2] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia
[3] Univ New South Wales, Sydney, NSW, Australia
[4] Prince Wales Clin Sch, Sydney, NSW, Australia
[5] Sydney Childrens Hosp, Kids Canc Ctr, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S46.006
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Determining the impact of chemotherapy-induced peripheral neuropathy: A survey of cancer survivors.
    Battaglini, Eva
    Goldstein, David
    Park, Susanna
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] DISTINCT SENSORY PROFILES IN CANCER SURVIVORS WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
    Mausisa, Grace
    Cooper, Bruce
    Paul, Steven
    Kober, Kord
    Miaskowski, Christine
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [43] Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
    K. Kanda
    K. Fujimoto
    R. Mochizuki
    K. Ishida
    B. Lee
    BMC Cancer, 19
  • [44] Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort
    Kalyan Sreeram
    Randell Seaton
    Mark K. Greenwald
    Mandana Kamgar
    Hadeel Assad
    Tara Baird
    Ann G. Schwartz
    Julie Ruterbusch
    Michael S. Simon
    Cancer Causes & Control, 2023, 34 : 459 - 468
  • [45] DIFFERENCES IN THE SYMPTOM EXPERIENCE OF CANCER SURVIVORS WITH AND WITHOUT CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
    Xu, Ling
    Kober, Kord
    Cooper, Bruce
    Paul, Steven
    Conley, Yvette
    Levine, Jon
    Miaskowski, Christine
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : E169 - E169
  • [46] Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
    J. Matt McCrary
    David Goldstein
    Carolina X. Sandler
    Benjamin K. Barry
    Michael Marthick
    Hannah C. Timmins
    Tiffany Li
    Lisa Horvath
    Peter Grimison
    Susanna B. Park
    Supportive Care in Cancer, 2019, 27 : 3849 - 3857
  • [47] Chemotherapy-induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-term Quality of Life
    Battaglini, Eva
    Goldstein, David
    Park, Susanna
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 548 - 548
  • [48] CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IS ASSOCIATED WITH REDUCED EXECUTIVE FUNCTION IN CHEMOTHERAPY TREATED CANCER SURVIVORS
    McNeish, Brendan
    Hehir, Michael
    Dittus, Kim
    Redfern, Mark
    Rosano, Caterina
    Richardson, James
    Kolb, Noah
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S74 - S75
  • [49] Patterns of Physical Therapy Referral and Subsequent Attendance Among Childhood Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy at a Regional Childhood Cancer Survivorship Clinic
    Kang, Lixin
    Kadan-Lottick, Nina S.
    Rotatori, Jaime
    Kujawski, Sophia E.
    Messerschmidt, Emily
    Auerbach, Claudia
    Balsamo, Lyn M.
    Lustberg, Maryam B.
    Ma, Xiaomei
    Rodwin, Rozalyn L.
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (05)
  • [50] INFLAMMATORY AND CLINICAL RISK FACTORS FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
    Kleckner, Ian
    Jusko, Todd
    Culakova, Eva
    Kleckner, Amber S.
    Asare, Matthew
    Inglis, Julia E.
    Loh, Melissa
    Peppone, Luke J.
    Miller, Jessica
    Melnik, Marianne
    Kasbari, Samer
    Ossip, Deborah
    Mustian, Karen M.
    ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S223 - S223